A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
about
Treatment of nongout joint deposition diseases: an updateNitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinismOchronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinoneFirst report of a deletion encompassing an entire exon in the homogentisate 1,2-dioxygenase gene causing alkaptonuria.Aortic stenosis and vascular calcifications in alkaptonuriaPharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)Reversible keratopathy due to hypertyrosinaemia following intermittent low-dose nitisinone in alkaptonuria: a case report.The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical AnalysisNitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.Relationship Between Serum Concentrations of Nitisinone and Its Effect on Homogentisic Acid and Tyrosine in Patients with AlkaptonuriaAge-Related Deviation of Gait from Normality in Alkaptonuria.Metabolic Effects of Increasing Doses of Nitisinone in the Treatment of Alkaptonuria.Brown urine and black hip.Alkaptonuria: leading to the treasure in exceptions.Alkaptonuria is a novel human secondary amyloidogenic diseaseRedox proteomics gives insights into the role of oxidative stress in alkaptonuria.Alkaptonuria.The role of nitisinone in tyrosine pathway disorders.Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria.Progress toward improved therapies for inborn errors of metabolism.Acute fatal metabolic complications in alkaptonuria.A role for interleukins in ochronosis in a chondrocyte in vitro model of alkaptonuria.Osteoarticular cells tolerate short-term exposure to nitisinone-implications in alkaptonuria.The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool.Cartilage biomarkers in the osteoarthropathy of alkaptonuria reveal low turnover and accelerated ageing.Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.Alkaptonuria and Pompe disease in one patient: metabolic and molecular analysis.Osler's sign revisited.A simplified staging system based on the radiological findings in different stages of ochronotic spondyloarthropathy.Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury.Blackish Pigmentation of the Aorta in Patient with Alkaptonuria and Heyde's Syndrome.Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria.Nitisinone-Induced Keratopathy in Alkaptonuria: A Challenging Diagnosis Despite Clinical Suspicion.Liver Transplantation for Hereditary Tyrosinaemia Type 1 in the United Kingdom.Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment.Alkaptonuric ochronosis: a clinical study from Ardabil, Iran.Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features.From Weed Killer to Wonder Drug.
P2860
Q26852957-10B5EC94-3EA2-4F49-892E-0E47BE92E006Q28249590-72FC7ECD-F45A-4BD0-96C8-EE93B0F6FFDEQ28287543-48994E39-4404-4093-9FC7-0248B22763C5Q30366939-1480311D-CF7A-4A12-A82E-CBB8F0399948Q30504971-D9C5298B-0001-4141-9139-B6B62A14A24EQ33993821-91677BE7-06CE-41FC-9232-2CB5F1605EC3Q34560227-76B69011-BD3B-4E32-B5EF-5EFDEDD241E1Q36090565-52A6FA32-58A4-45F0-933A-1AEF431530ACQ36090570-CBD5D413-A6A5-4A90-A7FE-BE4E9CC51F5DQ36090577-387C3158-EE7C-4044-B8A8-7B98A49CBA2FQ36090586-80D4DBE1-D840-4BDB-BBF7-A89CDE63D761Q36090590-14CD5BBE-83ED-4A08-A039-3228AACA0824Q36315143-454DFD24-8F7B-48A8-96DF-35CFCD458953Q36433474-71618CE2-4A7F-4CAB-904B-D8BE4380B8F1Q37209177-84754BD4-D9E8-4F5A-9DB4-2A7E8E204C29Q38160929-A8ECD6B0-7FCB-4A7A-BA9F-566F95065518Q38227178-FB6B2FFE-7FF1-48E5-9501-94D5A4DCF8F5Q38255379-29420B4E-7C31-4707-8907-319A8416699EQ38414587-DDA00216-B300-4297-BD9D-39922B262E2AQ38601073-A5C96C1A-B111-4924-A3EA-22798A68BBB0Q38644004-A10FDB07-2E30-42D3-86F6-B66E44965F6FQ38827337-B995923D-09FF-48F5-A778-CF3A4815E615Q38869592-E8D2C233-8FB6-4851-93E1-F9E4139D0AFFQ39024172-2D84270C-CBC0-40EC-9C1F-A1ACD3A4C311Q39061550-7E85246C-C4D6-4A5E-9B8A-4DF094AF7A0CQ39147959-D89992B6-8014-468A-976E-C8C530F4B220Q39944647-ED62C15A-078D-4FA4-A3A6-BC9A39569766Q40413861-F57F1685-1A9D-43D8-90E8-6B8808F7159FQ42383123-5FBEFE7B-0549-4090-A518-9E1809F9E31AQ42545345-DC8F3D6F-E8B4-4687-B350-3C502B8A0342Q43123162-E78F254E-9DAB-44A2-970D-4FA46384DF40Q43124913-EE7981E1-77F8-4606-920D-9F271D450F89Q47753281-E9897500-EE9C-4049-9535-030517A3CC3BQ47844194-1A9B65DF-1189-43CA-B6F4-65FF84EE5577Q48583044-3E7AF16A-D54E-41B2-8593-8CD828AEF644Q49935371-534C252B-2B55-4A56-AB64-BC24EB31FAC5Q50226081-E737CCA1-0353-4CBF-B29E-1D3C048AA453Q50850348-E3C0FBD0-440D-40A0-A80B-3AA7D142C4BCQ52588914-96EE5E00-DC5C-4510-B5C2-93F617B91124Q53136159-A5AF1A19-8471-4410-9241-F210816DDF64
P2860
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@ast
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@en
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@nl
type
label
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@ast
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@en
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@nl
prefLabel
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@ast
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@en
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@nl
P2093
P2860
P1476
A 3-year randomized therapeutic trial of nitisinone in alkaptonuria
@en
P2093
Ekaterini Tsilou
Elizabeth Moylan
Isa Bernardini
James C Reynolds
James Troendle
Joy Bryant
Kevin E O'Brien
Michael A Kayser
Monique B Perry
Pim Suwannarat
P2860
P304
P356
10.1016/J.YMGME.2011.04.016
P407
P577
2011-08-01T00:00:00Z